These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia]. Sampaolo G, Faloia E, Sarzani R, Bartolacci V, Schiavo P, Butini L, Morosini P. Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882 [No Abstract] [Full Text] [Related]
5. Human pancreatic growth hormone-releasing factor (hpGRF-44) in acromegaly before and after adenomectomy. Modifications induced by somatostatin (GHRIH) infusion. Arosio M, Ambrosi B, Guglielmino L, Faglia G. J Endocrinol Invest; 1985 Oct; 8(5):449-53. PubMed ID: 2867112 [Abstract] [Full Text] [Related]
6. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Hizuka N, Takano K, Wakabayashi I, Demura H, Ling N. J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226 [Abstract] [Full Text] [Related]
7. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine. Chiodini PG, Liuzzi A, Dallabonzana D, Oppizzi G, Verde GG. J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270 [Abstract] [Full Text] [Related]
10. Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration. Pieters GF, Smals AE, Hermus AR, Smals AG, Benraad TJ, Kloppenborg PW. Clin Endocrinol (Oxf); 1984 Dec; 21(6):701-7. PubMed ID: 6150772 [Abstract] [Full Text] [Related]
11. Human pancreatic growth hormone releasing factor (hpGRF): GRF- and GH-levels after bolus injection and infusion of hpGRF. von Werder K, Losa M, Stalla GK, Bock L, Müller OA. Acta Neurochir (Wien); 1985 Dec; 75(1-4):81-7. PubMed ID: 2986424 [Abstract] [Full Text] [Related]
12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly. Losa M, Schopohl J, König A, Müller OA, von Werder K. J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026 [Abstract] [Full Text] [Related]
13. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly. Losa M, Oeckler R, Schopohl J, Müller OA, Alba-Lopez J, von Werder K. J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918 [Abstract] [Full Text] [Related]
14. Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. Vance ML, Borges JL, Kaiser DL, Evans WS, Furlanetto R, Thominet JL, Frohman LA, Rogol AD, MacLeod RM, Bloom S. J Clin Endocrinol Metab; 1984 May; 58(5):838-44. PubMed ID: 6423660 [Abstract] [Full Text] [Related]
15. Effect of dexamethasone on growth hormone (GH) response to growth hormone releasing hormone in acromegaly. Nakagawa K, Akikawa K, Matsubara M, Kubo M. J Clin Endocrinol Metab; 1985 Feb; 60(2):306-10. PubMed ID: 3917458 [Abstract] [Full Text] [Related]